Veterinary Medicines

Norfloksacyna Vetos-Farma 10 g / 100 g Roztwór doustny

Authorised
  • Norfloxacin
Download as PDF

Product identification

Medicine name:
Norfloksacyna Vetos-Farma 10 g / 100 g Roztwór doustny
Active substance:
  • Norfloxacin
Target species:
  • Pigeon
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Norfloxacin
    10.00
    gram(s)
    /
    100.00
    gram(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Pigeon
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Przedsiebiorstwo Farmaceutyczne Okoniewscy Vetos Farma Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Przedsiebiorstwo Farmaceutyczne Okoniewscy Vetos Farma Sp. z o.o.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0227
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."